All In Biotech

Drug Trial Radar · NCT05662332

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 Administered Weekly Using a Fixed Dose Escalation Compared to Insulin Glargine in Insulin-Naïve Adults With Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 795 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

795

Actual

Start

Jan 14, 2023

Primary completion

Jul 19, 2024

Study completion Jul 19, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Dec 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to determine the efficacy and safety of insulin efsitora alfa (LY3209590) administered weekly using a fixed dose escalation compared to insulin glargine in adults with type 2 diabetes (T2D) who are starting basal insulin therapy for the first time.

Conditions

  • Type 2 Diabetes
  • T2D

Interventions

  • Insulin Efsitora AlfaDrug

    Administered SC

  • Insulin GlargineDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) [Noninferiority Analysis]Time frame: Baseline, Week 52

Locations

71 sites in 4 countries. Site status is shown where the registry gives one.

  • Cahaba Research

    Birmingham, Alabama

  • Syed Research Consultants Llc

    Sheffield, Alabama

  • AMCR Institute

    Escondido, California

  • Velocity Clinical Research, Gardena

    Gardena, California

  • National Research Institute - Huntington Park

    Huntington Park, California

  • National Research Institute - Wilshire

    Los Angeles, California

  • Diabetes Associates Medical Group

    Orange, California

  • Encompass Clinical Research

    Spring Valley, California

  • Millennium Clinical Trials

    Thousand Oaks, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Clinical Research of West Florida, Inc. (Clearwater)

    Clearwater, Florida

  • Suncoast Research Group

    Miami, Florida

  • Clinical Research of West Florida

    Tampa, Florida

  • Center for Advanced Research & Education

    Gainesville, Georgia

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii

  • Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative

    Springfield, Illinois

  • American Health Network of Indiana, LLC - Franklin

    Franklin, Indiana

  • American Health Network of Indiana, LLC - Muncie

    Muncie, Indiana

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • Clinvest Research LLC

    Springfield, Missouri

  • University Of Nebraska Medical Center

    Omaha, Nebraska

  • Mid Hudson Medical Research

    New Windsor, New York

  • Meridian Clinical Research, LLC

    Vestal, New York

  • Intend Research, LLC

    Norman, Oklahoma

  • Decpa, Llc

    Feasterville-Trevose, Pennsylvania

  • Office 18

    Pittsburgh, Pennsylvania

  • WR-Clinsearch, LLC

    Chattanooga, Tennessee

  • Private Practice - Dr. Osvaldo A. Brusco

    Corpus Christi, Texas

  • Dallas Diabetes Research Center

    Dallas, Texas

  • Prime Revival Research Institute

    Flower Mound, Texas

  • Endocrine Associates

    Houston, Texas

  • Endocrine Ips, Pllc

    Houston, Texas

  • North Hills Family Medicine/North Hills Medical Research

    North Richland Hills, Texas

  • Texas Valley Clinical Research

    Weslaco, Texas

  • Eastside Research Associates

    Redmond, Washington

  • Fundación Respirar

    Buenos Aires, Argentina

Showing 40 of 71 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.